Summary: Limited submission funding opportunity for Stanford faculty with PI eligibility (UTL, UML, and NTLR appointments) with a focus on pediatric cancer research. The SOLE nominee may apply in either the V Scholar OR the Translational program type. The RFAs for both pediatric programs are attached. A university-wide internal selection process is required.
Number of applicants permitted per institution: 1
Timeline:
Internal Stanford Cancer Institute deadline: April 22, 2024 (see internal submission guidelines below)
Stanford Cancer Institute will notify the applicant selected that he/she can proceed with the full application/proposal: April 26, 2024
Draft Recommendation Letter to Dr. Steve Artandi due to Stanford Cancer Institute: May 2, 2024
Stanford Cancer Institute to submit the nomination of the applicant to the V Foundation: May 10, 2024
The foundation will then contact the applicant to provide access to the online application system:
Institutional representative (RPM/RMG or CGO/OSR) deadline: June 10, 2020
Sponsor deadline: June 17, 2024
Program Guidelines:
RFAs sent only to invited institutions. The foundation prefers that this announcement is not distributed outside Stanford University therefore it cannot be posted on the Stanford Cancer Institute or RMG webpages. The program guidelines are not available on the sponsor’s website.
Pediatric Translational Cancer Research Grant: 2024 Request for Applications
Amount of funding: A four-year, $800,000 grant, paid in $200,000 annual installments. Indirect costs up to 10% of direct costs allowed. The V Foundation follows NIH Guidelines regarding salary caps. Institutions are welcome to supplement a grant recipient’s salary with institutional funds if desired.
Purpose: This Request for Applications (RFA) is specifically for pediatric cancer research through the Translational grant mechanism. Applicants may propose pediatric cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than 3 years from the end of the grant. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.
Special Focus: This RFA is specifically for pediatric cancer research that falls into preclinical/translational research as described above. Please note that research areas not included in this scope are epidemiology, behavioral science, and health services research.
Eligibility: The nominee must be the lead Principal Investigator (PI) on the Translational research team and must meet all of the following criteria by this nomination due date:
- Hold a tenure-track or tenured faculty position at their cancer research institution.
-
- Stanford eligibility clarification: the foundation has approved faculty with UTL, UML and NTLR positions.
- Not eligible: Clinician Educator (CE) faculty, Instructors, Clinical Instructors, Academic staff-research (i.e., research associates)
- Non-promotable, adjunct, affiliated, temporary, part-time, or acting faculty positions are not eligible for Principal Investigator nomination.
- Must be either a US Citizen or have a legal permit (temporary or permanent) to work in the US. This requirement does not apply to invited Canadian institutions.
Pediatric V Scholar Cancer Research Grant: 2024 Request for Applications
Amount of funding: A three-year, $600,000 grant, paid in $200,000 annual installments. No indirect costs allowed. The V Foundation follows NIH Guidelines regarding salary caps. Institutions are welcome to supplement a grant recipient’s salary with institutional funds if desired.
Purpose: This Request for Applications (RFA) is specifically for pediatric cancer research through the V Scholar grant mechanism. This award supports tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research. Emphasis for this grant mechanism is on supporting exceptional early career investigators at the Assistant Professor stage to be better positioned to leverage large R01 or similar sustaining grants.
Special Focus: This RFA is specifically for pediatric cancer research. Please note that research areas not included in this scope are epidemiology, behavioral science, and health services research.
Eligibility: The nominee must be the lead Principal Investigator (PI) on the Translational research team and must meet all of the following criteria by this nomination due date:
- V Scholar Applicants must have been appointed to their first full-time tenure track Assistant Professor position no more than 5 years prior to the nomination due date, and not yet promoted to Associate Professor.
-
- Stanford eligibility clarification: the foundation has approved faculty with UTL, UML and NTLR positions.
- Not eligible: Clinician Educator (CE) faculty, Instructors, Clinical Instructors, Academic staff-research (i.e., research associates)
- Either a US Citizen or a permanent legal resident in the US. This requirement does not apply to invited Canadian institutions.
- Possess at least 2 years post-doctoral (MD or PhD) fellowship training. For MDs, a minimum of one year is acceptable if only one year is required for their specialty.
- Clinical scientists are eligible if the research institution demonstrates that it will fully support the research applicant (e.g., dedicated lab space, committed research time, start-up funds).
- See RFA for exclusions. See 2024 V Scholar Decision Tree Handout for eligibility requirements.
STANFORD INTERNAL SUBMISSION GUIDELINES:
By April 22, 2024, please submit an internal proposal to the Stanford Cancer Institute HERE. Please upload a single pdf file containing these required documents:
Cover page
Please include: The 2024 V Foundation Pediatric Cancer Research Grant Program, Title of Proposal, and PI Contact Information (name, title, department, address, email)
Indicate the RFA category: V Scholar OR Translational Program
2 page research proposal summary
Format: Arial 11 font, single-spaced, 1 inch margins). References and figures are not included in the page limit.
PI NIH format biosketch
The attached 2024 V Foundation V Scholar Financial Worksheet (if applying under the V Scholar RFA)
This form does not need Dr. Steven Artandi’s signature at the internal proposal deadline (April 22, 2024). Dr. Artandi will review and sign the selected nominee’s worksheet with his recommendation letter for the official nomination.
Institutional representative: not applicable. You do not need to submit your internal proposal through your institutional official for approval. You may submit your internal proposal directly to SCI via the online submission portal.
Selection process:
Proposals will be reviewed by a Stanford Cancer Institute review committee. That committee will select the applicant to represent Stanford.
Questions? Please contact Gayle White at gwhite5@stanford.edu.
